Rigel Pharmaceuticals Inc
RIGL
NASDAQ
Biotechnology
$42.58
USD
+1.79 (+4.39%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $780.54M
Volume 224.0K
Peer Comparison Table
(1/4) | ||||||
|---|---|---|---|---|---|---|
ANNX | Annexon Inc | $856.08M | - | - | - | |
AURA | Aura Biosciences Inc | $793.34M | - | - | - | |
IMMX | Immix Biopharma Inc | $781.21M | - | - | - | |
RIGL | Rigel Pharmaceuticals Inc | $780.54M | 2.42 | +3.3% | - | |
BBOT | BridgeBio Oncology Therapeutics Inc | $743.39M | - | - | - | |
MNPR | Monopar Therapeutics Inc | $737.90M | - | - | - | |
FTH | Faeth Therapeutics, Inc | $737.74M | - | - | - | |
GYRE | Gyre Therapeutics Inc | $736.94M | - | +16.3% | - | |
ACHV | Achieve Life Sciences Inc | $725.46M | - | -89.3% | - | |
STTK | Shattuck Labs Inc | $661.53M | - | -78.3% | - |
Top Peer by Growth
Gyre Therapeutics Inc
+16.3% YoY Revenue
Lowest P/E Ratio
Rigel Pharmaceuticals Inc
2.42x P/E
Best 1-Year Return
Shattuck Labs Inc
+882.3% Return